| Lisa Susan Lockard, OTR | |
|
611 New York Ave, Absecon, NJ 08201-1627 | |
| (609) 646-1368 | |
| (609) 646-1368 |
| Full Name | Lisa Susan Lockard |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 611 New York Ave, Absecon, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992975858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 46TR00337800 (New Jersey) | Primary |
| Provider Name | Cross Training Rehabilitation, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1386986719 PECOS PAC ID: 7012151228 Enrollment ID: O20130910000075 |
News Archive
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.
Administration attorneys defended on Friday the part of President Barack Obama's healthcare law that expands the Medicaid program for the poor and disabled and said Congress has the power to set the terms under which it will disburse funds to the states.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
› Verified 2 days ago
| Provider Name | Ability Rehab Services, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215490404 PECOS PAC ID: 2769816628 Enrollment ID: O20191231000662 |
News Archive
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.
Administration attorneys defended on Friday the part of President Barack Obama's healthcare law that expands the Medicaid program for the poor and disabled and said Congress has the power to set the terms under which it will disburse funds to the states.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Susan Lockard, OTR 611 New York Ave, Absecon, NJ 08201-1627 Ph: (609) 646-1368 | Lisa Susan Lockard, OTR 611 New York Ave, Absecon, NJ 08201-1627 Ph: (609) 646-1368 |
News Archive
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.
Administration attorneys defended on Friday the part of President Barack Obama's healthcare law that expands the Medicaid program for the poor and disabled and said Congress has the power to set the terms under which it will disburse funds to the states.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
› Verified 2 days ago
Lisa Amaquandoh, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 117 Mohawk Ln, Absecon, NJ 08201 Phone: 609-277-5085 | |
Ability Rehab Services, Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 611 New York Ave, Absecon, NJ 08201 Phone: 609-204-5289 | |
Maggie Ann Seel, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1020 Pitney Rd, Absecon, NJ 08201 Phone: 609-646-5400 | |
Christopher Guishard I, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1020 Pitney Rd, Absecon, NJ 08201 Phone: 609-646-5400 |